|
![]()
|
While the technology is applicable to a wide range of surgical procedures, Bioconnect is initially focused on improving vascular access in hemodialysis patients. There are over one million patients suffering from end stage renal disease who require weekly vascular access for hemodialysis.
*Optiflow AV is under investigation and not available for sale. |
|